The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

被引：10
|
作者：
Kockerols, Camille C. B. [1 ]
Geelen, Inge [2 ]
Levin, Mark-David [1 ]
Janssen, Jeroen J. W. M. [3 ]
Dinmohamed, Avinash G. [4 ,5 ]
Hoogendoorn, Mels [6 ]
Cornelissen, Jan J. [2 ]
Westerweel, Peter E. [1 ]
机构：
[1] Albert Schweitzer Hosp, Dept Internal Med, Hematol, Dordrecht, Netherlands
[2] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
[3] Amsterdam Univ Med Ctr, Dept Hematol, Iocat VU Med Ctr, Amsterdam, Netherlands
[4] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[5] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[6] Med Ctr Leeuwarden, Dept Hematol, Leeuwarden, Netherlands
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 08期
关键词：
D O I：
10.3324/haematol.2021.280501
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1940 / 1943
页数：4
相关论文
共 50 条
  • [1] Monocytic Crisis of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitor
    Tsunemine, Hiroko
    Arima, Hiroshi
    Itoh, Kiminari
    Sakane, Emiko Ishikawa
    Akasaka, Hiroshi
    Kodaka, Taiichi
    Takahashi, Takayuki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (03) : 227 - 233
  • [2] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the "Best" Therapy?
    Agrawal, Meetu
    Garg, Ravin J.
    Kantarjian, Hagop
    Cortes, Jorge
    CURRENT ONCOLOGY REPORTS, 2010, 12 (05) : 302 - 313
  • [3] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the “Best” Therapy?
    Meetu Agrawal
    Ravin J. Garg
    Hagop Kantarjian
    Jorge Cortes
    Current Oncology Reports, 2010, 12 : 302 - 313
  • [4] Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
    Russo, Domenico
    Malagola, Michele
    Skert, Cristina
    Fili, Carla
    Bergonzi, Cesare
    Cancelli, Valeria
    Cattina, Federica
    CURRENT CANCER DRUG TARGETS, 2013, 13 (07) : 755 - 767
  • [5] Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the best therapy?
    Alfonso Quintás-Cardama
    Jorge Cortes
    Current Oncology Reports, 2009, 11 : 337 - 345
  • [6] Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era
    Comert, Melda
    Baran, Yusuf
    Saydam, Guray
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2013, 3 (03): : 191 - 200
  • [7] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the Best Therapy?
    Quintas-Cardama, Alfonso
    Cortes, Jorge
    CURRENT ONCOLOGY REPORTS, 2009, 11 (05) : 337 - 345
  • [8] Allogeneic stem cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era
    Alshomar, Ahmad
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2022, 47 (02): : 81 - 87
  • [9] Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era
    Gunnarsson, Niklas
    Leif, Stenke
    Hoglund, Martin
    Sandin, Fredrik
    Bjorkholm, Magnus
    Dreimane, Arta
    Lambe, Mats
    Markevarn, Berit
    Olsson-Stromberg, Ulla
    Richter, Johan
    Wadenvik, Hans
    Wallvik, Jonas
    Sjalander, Anders
    BLOOD, 2014, 124 (21)
  • [10] Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
    Castillo, Dan Ran
    Park, Daniel
    Mehta, Akhil
    Kaur, Simmer
    Nguyen, Anthony
    Akhtari, Mojtaba
    HEMATOLOGY REPORTS, 2022, 14 (01) : 45 - 53
12345